chr1-231529292-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -15 ACMG points: 0P and 15B. BP4_ModerateBP6_Very_StrongBP7BS2
The NM_005999.3(TSNAX):c.54C>T(p.Phe18Phe) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0022 in 1,614,122 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0016 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0023 ( 7 hom. )
Consequence
TSNAX
NM_005999.3 synonymous
NM_005999.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.658
Publications
1 publications found
Genes affected
TSNAX (HGNC:12380): (translin associated factor X) This gene encodes a protein which specifically interacts with translin, a DNA-binding protein that binds consensus sequences at breakpoint junctions of chromosomal translocations. The encoded protein contains bipartite nuclear targeting sequences that may provide nuclear transport for translin, which lacks any nuclear targeting motifs. [provided by RefSeq, Jul 2008]
TSNAX-DISC1 (HGNC:49177): (TSNAX-DISC1 readthrough (NMD candidate)) This gene represents naturally occurring read-through transcription between the neighboring TSNAX (translin-associated factor X) and DISC1 (disrupted in schizophrenia 1) genes on chromosome 1. Alternative splicing results in multiple transcript variants, all of which are candidates for nonsense-mediated mRNA decay (NMD) and are unlikely to be protein-coding. These alterations in gene processing may be associated with risk for psychiatric illness, most notably, schizophrenia. [provided by RefSeq, Nov 2010]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -15 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.43).
BP6
Variant 1-231529292-C-T is Benign according to our data. Variant chr1-231529292-C-T is described in ClinVar as [Benign]. Clinvar id is 784454.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.658 with no splicing effect.
BS2
High Homozygotes in GnomAdExome4 at 7 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TSNAX | NM_005999.3 | c.54C>T | p.Phe18Phe | synonymous_variant | Exon 2 of 6 | ENST00000366639.9 | NP_005990.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TSNAX | ENST00000366639.9 | c.54C>T | p.Phe18Phe | synonymous_variant | Exon 2 of 6 | 1 | NM_005999.3 | ENSP00000355599.3 | ||
TSNAX-DISC1 | ENST00000602956.5 | n.54C>T | non_coding_transcript_exon_variant | Exon 2 of 13 | 2 | ENSP00000473532.1 |
Frequencies
GnomAD3 genomes AF: 0.00164 AC: 249AN: 152148Hom.: 0 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
249
AN:
152148
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00193 AC: 479AN: 248728 AF XY: 0.00216 show subpopulations
GnomAD2 exomes
AF:
AC:
479
AN:
248728
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00225 AC: 3293AN: 1461856Hom.: 7 Cov.: 31 AF XY: 0.00229 AC XY: 1666AN XY: 727230 show subpopulations
GnomAD4 exome
AF:
AC:
3293
AN:
1461856
Hom.:
Cov.:
31
AF XY:
AC XY:
1666
AN XY:
727230
show subpopulations
African (AFR)
AF:
AC:
8
AN:
33480
American (AMR)
AF:
AC:
65
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
AC:
1
AN:
26134
East Asian (EAS)
AF:
AC:
2
AN:
39700
South Asian (SAS)
AF:
AC:
327
AN:
86250
European-Finnish (FIN)
AF:
AC:
155
AN:
53400
Middle Eastern (MID)
AF:
AC:
6
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
2610
AN:
1112006
Other (OTH)
AF:
AC:
119
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.449
Heterozygous variant carriers
0
169
338
507
676
845
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.00164 AC: 250AN: 152266Hom.: 0 Cov.: 33 AF XY: 0.00167 AC XY: 124AN XY: 74460 show subpopulations
GnomAD4 genome
AF:
AC:
250
AN:
152266
Hom.:
Cov.:
33
AF XY:
AC XY:
124
AN XY:
74460
show subpopulations
African (AFR)
AF:
AC:
12
AN:
41546
American (AMR)
AF:
AC:
23
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3468
East Asian (EAS)
AF:
AC:
0
AN:
5188
South Asian (SAS)
AF:
AC:
18
AN:
4826
European-Finnish (FIN)
AF:
AC:
39
AN:
10614
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
158
AN:
68010
Other (OTH)
AF:
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
14
28
42
56
70
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
4
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Apr 16, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.